Saturday, October 29, 2016: 12:30 PM-2:00 PM
Room: Poster Hall
Learning Objectives:
.
Tracks: Adult ID
Presentations:
Dasatinib Use May Be a Novel Risk Factor for Cytomegalovirus (CMV) Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)
Daniel Prestes, MD
;
Esther Arbona, MD
;
Alexandra Nevett Fernandez, MD
;
Sophia Koo, MD
;
Vincent Ho, MD
;
John Koreth, MD
;
Sarah P. Hammond, MD
;
Nicolas Issa, MD
;
Lindsey Baden, MD
;
Francisco M. Marty, MD, FIDSA
Maribavir Versus Valganciclovir for Preemptive Treatment of Cytomegalovirus (CMV) Viremia: A Randomized, Dose-Ranging, Phase 2 Study Among Hematopoietic Stem Cell Transplant (SCT) and Solid Organ Transplant (SOT) Recipients
Johan Maertens, MD, PhD
;
Catherine Cordonnier, MD
;
Peter Jaksch, MD
;
Xavier Poiré, MD
;
Jingyang J Wu, MS
;
Anna Wijatyk, MD
;
Faouzi Saliba, MD
;
Oliver Witzke, MD
;
Stephen Villano, MD
Impact of Viral Load on Eradication of Cytomegalovirus (CMV) Viremia Amongst High-risk Allogeneic Stem Cell Transplant (SCT) Recipients
Jose F. Camargo, MD
;
Luis Shimose, MD
;
Maria X. Bueno, MD
;
Rossana Rosa, MD
;
Nikeshan Jeyakumar, MHS
;
Michele I Morris, MD, FIDSA
;
Lilian M. Abbo, MD
;
Jacques Simkins, MD
;
Maritza C. Alencar, DNP, ARNP-BC
;
Cara Benjamin, PhD
;
Mark Goodman, MD
;
John J. Byrnes, MD
;
Lazaros J. Lekakis, MD
;
Denise Pereira, MD
;
Krishna V. Komanduri, MD
Establishing Viral Load Cut-off for Early Diagnosis of Cytomegalovirus Infection in Renal Transplant Recipients Using International Standardized Real-time PCR Assay
William Morgan, Medical Student
;
Samaa Lutfi, Medical Student
;
Rachna Jayaprakash, MD
;
Odaliz Abreu Lanfranco, MD
;
Anita Patel, MD
;
Linoj Samuel, PhD., D(ABMM)
;
Ramon Del Busto, MD
;
George Alangaden, MD, FIDSA
;
Mayur Ramesh, MD
A Prospective Observational Study to Evaluate a Cytomegalovirus(CMV)–specific T-SPOT® Assay in Hematopoietic Stem Cell Transplant Recipients: The REACT Study Interim Data Review
Ella Ariza-Heredia, MD
;
Dimpy P. Shah, MD, MSPH
;
Firas El Chaer, MD
;
Kathleen Mullane, DO, FIDSA
;
Scott Rowley, MD, FACP
;
Pranatharthi Chandrasekar, MD, FIDSA
;
Drew J. Winston, MD
;
Parameswaran Hari, MD
;
Heather Gillis, MS, MBA
;
Rajneesh Nath, MD
;
Deepali Kumar, MD
;
Sherif Mossad, MD, FIDSA
;
Per Ljungman, MD, PhD
;
Roy F. Chemaly, MD, MPH, FIDSA, FACP
The ability of CMV–specific ELISPOT assay to predict outcome of low level CMV reactivation in hematopoietic cell transplant recipients
Dimpy Shah, MD, MSPH, PhD
;
Ella Ariza-Heredia, MD
;
Firas El Chaer, MD
;
Lynn El Haddad, PhD
;
Danielle El-Haddad, MD
;
Amrita Prayag, M.B.B.S., MS
;
Lior Nesher, MD
;
Katy Rezvani, MD, PhD
;
Elizabeth Shpall, MD
;
Roy F. Chemaly, MD, MPH, FIDSA, FACP
Cytomegalovirus Infection in T Cell Replete Peripheral Blood Stem Cell Transplant with Post-Transplant Cyclophosphamide- A Single Center Experience
Zainab Shahid, MD
;
Jim Symanowski, Ph.D
;
Sarah Lestrange, BS
;
Saad Usmani, MD
;
Michael Grunwald, MD
;
Jonathan Gerber, MD
;
Nilanjan Ghosh, MD
;
Lewis Mccurdy, MD
;
Omotayo Fasan, MD
;
Jing Ai, MD
;
Belinda Avalos, MD
;
Edward Copelan, MD
CME Credits: No CME credit is offered for this session.
ACPE Credits:
ACPE Number:
